Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

response to lapatinib

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Clinical data analysis reveals that the expression of the EphB4 receptor tyrosine kinase is significantly elevated in HER2… Expand
Is this relevant?
2018
2018
Human epidermal growth factor 2 (HER2) amplification represents a distinct molecular subgroup of colorectal cancers that is… Expand
Is this relevant?
2015
2015
  • Trevor Dennie
  • Case reports in oncological medicine
  • 2015
  • Corpus ID: 17875618
Carcinoma of the lacrimal gland is a rare malignancy, limiting opportunities to develop new therapeutic regimens through clinical… Expand
Is this relevant?
2013
2013
Lapatinib, a small molecule tyrosine kinase inhibitor is currently used in the treatment of HER2-positive breast cancer. The aim… Expand
  • figure 1
  • figure 2
  • table 1
  • table I
  • figure 3
Is this relevant?
2011
2011
HER2-directed therapy has become an important agent in the treatment of metastatic breast cancer, and has altered the natural… Expand
Is this relevant?
2009
2009
Background: Lapatinib (L) is a potent and selective dual inhibitor of EGFR and HER2. In HER2 positive metastatic breast cancer… Expand
Is this relevant?